Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging

Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging

Immunohistochemical evaluation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 status stratify the different subtypes of breast cancer and define the treatment course. Triple-negative breast cancer (TNBC), which does not register receptor overexpression, is...

Full description

Bibliographic Details
Main Authors:	Juliana Pereira Lopes Gonçalves, Christine Bollwein, Aurelia Noske, Anne Jacob, Paul Jank, Sibylle Loibl, Valentina Nekljudova, Peter A. Fasching, Thomas Karn, Frederik Marmé, Volkmar Müller, Christian Schem, Bruno Valentin Sinn, Elmar Stickeler, Marion van Mackelenbergh, Wolfgang D. Schmitt, Carsten Denkert, Wilko Weichert, Kristina Schwamborn
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	International Journal of Molecular Sciences
Subjects:	mass spectrometry imaging breast cancer proteomics tissue typing histopathology
Online Access:	https://www.mdpi.com/1422-0067/24/3/2860

Similar Items

Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer: Data From the GeparOcto‐GBG 84 Trial
by: Alexandra Maria Rüger, et al.
Published: (2020-12-01)

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
by: Jonas Leichsenring, et al.
Published: (2022-10-01)

Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial
by: Malgorzata Banys-Paluchowski, et al.
Published: (2019-08-01)

Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 study
by: Mattea Reinisch, et al.
Published: (2022-12-01)

MALDI Mass Spectrometry Imaging for the Distinction of Adenocarcinomas of the Pancreas and Biliary Tree
by: Christine Bollwein, et al.
Published: (2022-05-01)

An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas
by: Braicu Elena I, et al.
Published: (2011-07-01)

MALDI-MSI: A Powerful Approach to Understand Primary Pancreatic Ductal Adenocarcinoma and Metastases
by: Juliana Pereira Lopes Gonçalves, et al.
Published: (2022-07-01)

Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy
by: Jens Huober, et al.
Published: (2023-04-01)

The Impact of Histological Annotations for Accurate Tissue Classification Using Mass Spectrometry Imaging
by: Juliana Pereira Lopes Gonçalves, et al.
Published: (2021-10-01)

Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial.
by: Yasmin Issa-Nummer, et al.
Published: (2013-01-01)

Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores
by: Kerstin Riecke, et al.
Published: (2021-02-01)

A Mass Spectrometry Imaging Based Approach for Prognosis Prediction in UICC Stage I/II Colon Cancer
by: Benedikt Martin, et al.
Published: (2021-10-01)

Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain Metastases
by: Elena Laakmann, et al.
Published: (2020-09-01)

Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker?
by: Björn Konukiewitz, et al.
Published: (2021-10-01)

Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups
by: Maxime Schmitt, et al.
Published: (2021-12-01)

Anti-hormonal maintenance treatment with the CDK4/6 inhibitor ribociclib after 1st line chemotherapy in hormone receptor positive / HER2 negative metastatic breast cancer: A phase II trial (AMICA)
by: Thomas Decker, et al.
Published: (2023-12-01)

Mass Spectrometry Imaging Spatial Tissue Analysis toward Personalized Medicine
by: Juliana P. L. Gonçalves, et al.
Published: (2022-07-01)

Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapy
by: David Krug, et al.
Published: (2024-04-01)

The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy
by: Pauline Wimberger, et al.
Published: (2023-03-01)

High expression of insulinoma‐associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin
by: Anne‐Sophie Litmeyer, et al.
Published: (2023-11-01)

Influence of the Computer-Aided Decision Support System Design on Ultrasound-Based Breast Cancer Classification
by: Zuzanna Anna Magnuska, et al.
Published: (2022-01-01)

Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial
by: Bernd Gerber, et al.
Published: (2022-01-01)

Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low Patients
by: Fabian Stögbauer, et al.
Published: (2023-07-01)

Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE
by: Sibylle Loibl, et al.
Published: (2022-09-01)

Immunohistological Expression of SOX-10 in Triple-Negative Breast Cancer: A Descriptive Analysis of 113 Samples
by: Katharina Kriegsmann, et al.
Published: (2020-09-01)

Post‐neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage‐ and regression‐grade independent prognostic information in intestinal‐type gastric adenocarcinoma
by: Moritz Jesinghaus, et al.
Published: (2022-09-01)

Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications
by: Muhammad Hasan Bashari, et al.
Published: (2016-02-01)

Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancer.
by: Zsuzsanna Varga, et al.
Published: (2013-01-01)

Heterogeneity of prostate-specific membrane antigen (PSMA) and PSMA-ligand uptake detection combining autoradiography and postoperative pathology in primary prostate cancer
by: Hui Wang, et al.
Published: (2023-11-01)

Design and trends in home information systems
by: Baal-Schem, Jacob
Published: (2013)

Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications
by: Muhammad Hasan Bashari, et al.
Published: (2024-04-01)

Predictors of CIN2+ in Patients with PAP III-P (ASC-H): A Cross-Sectional Study
by: Luana Antonia Kaiser, et al.
Published: (2023-03-01)

Evaluation of urinary continence status and its influence on quality of life after gyneco-oncological treatment of female pelvic malignancies at an oncological center
by: Maryam Zafarnia, et al.
Published: (2022-10-01)

Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy
by: Patrik Pöschke, et al.
Published: (2023-09-01)

Human Primary Breast Cancer Stem Cells Are Characterized by Epithelial-Mesenchymal Plasticity
by: Juliane Strietz, et al.
Published: (2021-02-01)

Tumor Necrosis Factor-α (TNFα) Stimulates Triple-Negative Breast Cancer Stem Cells to Promote Intratumoral Invasion and Neovasculogenesis in the Liver of a Xenograft Model
by: Harini Narasimhan, et al.
Published: (2022-10-01)

PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant
by: Tom Degenhardt, et al.
Published: (2023-05-01)

BCL-2, HER1, HER2, HER3 and HER4 expression in primary colorectal adenocarcinoma
by: Ahmad Zubir, Nurul Mahirah
Published: (2017)

Pathological Reporting of Radical Prostatectomy Specimens Following ICCR Recommendation: Impact of Electronic Reporting Tool Implementation on Quality and Interdisciplinary Communication in a Large University Hospital
by: Caroline Richter, et al.
Published: (2022-09-01)

A Glimmer of Hope for Patients with a T3 Transformation Zone: miRNAs Are Potential Biomarkers for Cervical Dysplasia
by: Julia Wittenborn, et al.
Published: (2023-12-01)